Biotricity Inc. announced it has signed its second distribution agreement with a top five US medical device distributor for the marketing and distribution of its two cardiac monitoring solutions (CMS) designed for cardiologists' patient use - Bioflux® and BiotresTM. The distribution agreement covers Bioflux and Biotres and will be distributed directly to hospitals and clinics for professional medical utilization with suitable patients.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 USD | +2.75% | -6.67% | -2.61% |
Apr. 26 | Biotricity Inc. Announces High Demand for Its Latest Device, Biotres Pro | CI |
Apr. 19 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-2.61% | 10.32M | |
-7.13% | 3.08B | |
-14.58% | 84.02M | |
-45.91% | 51.53M | |
+10.14% | 50.41M |
- Stock Market
- Equities
- BTCY Stock
- News Biotricity, Inc.
- Biotricity, Inc. Signs Distribution Agreement with Top 5 Distributor for Its Cardiac Monitoring Solutions